EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Cerium Phosphate–Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study

Ekaterina V Silina iD, Natalia E Manturova iD, Elena L Chuvilina, Akhmedali A Gasanov, Olga I Andreeva, Elena B Artyushkova, Mikhail P Gladchenko, Aleksandr V Ivanov iD, Victor T Dudka, Sergey Y Mironov, Daria D Tkachenko iD, Anatoly V Skalny iD und 3 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27167476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ekaterina V Silina und 14 weiteren Autor:innen. Beteiligte Einrichtung: I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Cerium, Nanocomposites, Citric Acid, Regenerative Medicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the study was to synthesize nanocomposites based on cerium orthophosphate stabilized with citrate at different ratios for biomedical applications, and to evaluate its safety in different animal species. Nanocomposites were synthesized using four different initial mass ratios of Ce(NO3)3 × 6H2O to citric acid: 1:5 (Ce:5CA), 1:3 (Ce:3CA), 1:1 (Ce:1CA), and 1:0.5 (Ce:0.5CA). The obtained products were characterized by a series of physicochemical methods including X-ray diffraction, transmission electron microscopy, and IR spectroscopy. Biomedical studies of the sols were performed to evaluate redox activity and their effects on the metabolism and proliferation of human fibroblasts. Safety studies were carried out in different animal species, including determination of the acute toxicity of the selected nanocomposite following application to intact skin and intragastric administration, as well as determination of subchronic toxicity using a model of acute experimental full-thickness skin wounds. According to the physicochemical studies, all synthesized nanocomposites contained nanocrystals with bimodal dimensions (width 3–10 nm, length 15–40 nm) and diffraction peaks characteristic of CePO4. IR spectroscopy demonstrated the formation of new chemical bonds. Antioxidant activity was observed for the Ce:3CA, Ce:1CA, and Ce:0.5CA samples, being most pronounced for Ce:1–0.5CA, whose antioxidant capacity exceeded that of ascorbic acid. In contrast, Ce:5CA exhibited pro-oxidant activity at all tested concentrations. Biocompatibility with human cells was demonstrated. Ce:0.5CA was identified as the most promising candidate for biomedical applications owing to its highest regenerative and antioxidant potential and its demonstrated safety in animals following topical and intragastric administration, as well as in wound models. Histomorphological examination of the internal organs supported the safety and potential of the developed nanocomposites for skin regeneration and wound healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeriumNanocompositesCitric AcidRegenerative MedicinePhosphatesAnimalsHumansWound HealingAntioxidantsFibroblastsSkinMiceMale

Stichwörter der Autor:innen

IR spectroscopyTEMX-ray diffractionantioxidantscerium (III) orthophosphatecerium phosphatecitratecitric acidmicemorphologynanocompositenanoparticlesratsredox activityregenerative medicine

Substanzen

CeriumCitric AcidPhosphatescerium phosphateAntioxidants

Autor:innen und Institutionen

  • I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia.
  • Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow 117997, Russia.
  • LANHIT LLC, Moscow 105118, Russia.
  • Kursk State Medical University, Ministry of Health of the Russian Federation, Kursk 305041, Russia.
  • Yaroslavl State University, Ministry of Science and Higher Education of the Russian Federation, Yaroslavl 150003, Russia.
  • National University of Science & Technology MISIS, Ministry of Science and Higher Education of the Russian Federation, Moscow 119049, Russia.

ORCID-Profile: Ekaterina V Silina, Natalia E Manturova, Aleksandr V Ivanov, Daria D Tkachenko, Anatoly V Skalny, Alexey A Tinkov, Natalia Y Tabachkova, Victor A Stupin

Förderung

  • Russian Science Foundation

Zitieren

APA

Silina, E. V., Manturova, N. E., Chuvilina, E. L., Gasanov, A. A., Andreeva, O. I., Artyushkova, E. B., Gladchenko, M. P., Ivanov, A. V., Dudka, V. T., Mironov, S. Y., Tkachenko, D. D., Skalny, A. V., Tinkov, A. A., Tabachkova, N. Y., & Stupin, V. A. (2026). Novel Cerium Phosphate–Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27167476

Vancouver

Silina EV, Manturova NE, Chuvilina EL, Gasanov AA, Andreeva OI, Artyushkova EB, et al. Novel Cerium Phosphate–Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27167476

BibTeX
@article{Silina2026,
  author = {Silina, Ekaterina V and Manturova, Natalia E and Chuvilina, Elena L and Gasanov, Akhmedali A and Andreeva, Olga I and Artyushkova, Elena B and Gladchenko, Mikhail P and Ivanov, Aleksandr V and Dudka, Victor T and Mironov, Sergey Y and Tkachenko, Daria D and Skalny, Anatoly V and Tinkov, Alexey A and Tabachkova, Natalia Y and Stupin, Victor A},
  title = {Novel Cerium Phosphate–Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27167476}
}
Kostenlos starten →